The identification and characterization of these spliceogenic MYBPC3 variants by the pioneer studies represented the first evidence that mutations in the MYBPC3 gene cause familial hypertrophic cardiomyopathy. This evidence concerns the gene MYBPC3 and hypertrophic cardiomyopathy.